Psychiatry Research
Volume 105, Issue 1 , Pages 23-32 , 15 December 2001

Hyperactive phosphoinositide signaling pathway in platelets of depressed patients: effect of desipramine treatment

Received 24 April 2001 ,Revised 26 September 2001 ,Accepted 28 September 2001.

References 

  1. Bell RL, Majerus PW. Thrombin-induced hydrolysis of phosphatidylinositol in human platelets. Journal of Biological Chemistry. 1980;225:1790–1972
  2. Berridge MJ. Rapid accumulation of inositol triphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol. Biochemistry Journal. 1993;212:849–858
  3. Berridge MJ, Irvine RE. Inositol phosphates and cell signaling. Nature. 1989;341:197–205
  4. Bunney WE, Davis JM. Norepinephrine in depressive reactions. Archives of General Psychiatry. 1965;13:483–494
  5. Charney DS, Heninger GR, Sternberg DE, Hafstad KM, Giddings S, Landis DH. Adrenergic receptor sensitivity in depression. Archives of General Psychiatry. 1982;39:290–294
  6. Cockcroft S, Thomas GMH. Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors. Biochemical Journal. 1992;288:1–14
  7. Conn PJ, Sanders-Bush E. Biochemical characterization of serotonin stimulated phosphoinositide turnover. Life Sciences. 1986;88:663–669
  8. Conn PJ, Sanders-Bush E. Regulation of serotonin stimulated phosphoinositide hydrolysis: relation to the serotonin 5HT2 binding site. Journal of Neuroscience. 1986;6:3669–3675
  9. de Chaffoy de Courcelles D, Roevens P, Wynants J, Van Belle H. Serotonin-induced alterations in inositol phospholipid metabolism in human platelets. Biochimica et Biophysica Acta. 1987;927:291–302
  10. Delgado PL, Price LH, Miller HL, Salomon RM, Aghajanian GK, Heninger GR, et al. Serotonin and the neurobiology of depression. Archives of General Psychiatry. 1994;51:865–874
  11. Dwivedi Y, Pandey GN. Effects of subchronic administration of antidepressants and anxiolytics on the levels of the α subunits of G proteins in the rat brain. Journal of Neural Transmission. 1997;104:747–760
  12. Gillman AG. G protein and dual control of adenylyl cyclase. Cell. 1984;36:577–579
  13. Godfrey PP, Putney JW. Receptor mediated metabolism of the phosphoinositides and phosphatidic acid in rat lacrimal acinar cells. Biochemical Journal. 1984;218:187–195
  14. Grossman F, Manji HK, Potter WZ. Platelet α2-adrenoreceptors in depression: a critical examination [Review]. Journal of Psychopharmacology. 1993;7:4–18
  15. Gurguis GNM, Vo SP, Griffith JM, Rush AJ. Platelet alpha2A-adrenoceptor function in major depression: GI coupling, effects of imipramine and relationship to treatment outcome. Psychiatry Research. 1999;89:73–95
  16. Gurguis GNM, Vo SP, Griffith JM, Rush AJ. Neutrophil beta(2)-adrenoceptor function in major depression: G(s) coupling, effects of imipramine and relationship to treatment outcome. European Journal of Pharmacology. 1999;15:135–144
  17. Halper JP, Brown RP, Sweeney JA, Kocsis JH, Peters A, Mann JJ. Blunted β-adrenergic responsivity of peripheral blood mononuclear cells in endogenous depression. Archives of General Psychiatry. 1988;45:241–244
  18. Huang ME, Detwiler TC. Thrombin-induced phosphoinositide hydrolysis in platelets: receptor occupancy and desensitization. Biochemical Journal. 1987;242:11–18
  19. Jakobs KH, Watanabe Y, Bauer S. Interaction between hormone-sensitive cyclase system and the phosphoinositide metabolizing pathway in human platelets. Journal of Cardiovascular Pharmacology. 1986;8(Suppl. 8):S61–S64
  20. Jope RS, Song L, Powers R. Agonist-induced, GTP-dependent phosphoinositide hydrolysis in postmortem human brain membranes. Journal of Neurochemistry. 1994;62:180–186
  21. Kafka MS, Paul SM. Platelet α-2-adrenoceptors in depression. Archives of General Psychiatry. 1986;43:91–95
  22. Karege F, Bovier P, Waltraut R, Gaillard JM. Platelet phosphoinositide signaling system: an over-stimulated pathway in depression. Biological Psychiatry. 1996;39:697–702
  23. Lapetina EG, Silo J, Ruggiero M. Thrombin induces serotonin secretion and aggregation independently of inositol phospholipids hydrolysis and protein phosphorylation in human platelets permeabilized with saponin. Journal of Biological Chemistry. 1985;260:7078–7083
  24. Majerus PW, Connolly TM, Deckmyn H, Ross TS, Bross TE, Ishii H, et al. The metabolism of phosphoinositide-derived messenger molecules. Science. 1986;234:1519–1526
  25. Manji HK. G proteins: implications for psychiatry. American Journal of Psychiatry. 1992;149:746–760
  26. Mann JJ, Brown RP, Halper JP, Sweeney JA, Kocsis JH, Stokes PE, et al. Reduced sensitivity of lymphocytes β-adrenergic receptors in patients with endogenous depression and psychomotor agitation. New England Journal of Medicine. 1985;313:715–720
  27. Mikuni M, Kusumi I, Kagaya A, Kuroda Y, Mori H, Takahashi K. Increased 5-HT-2 receptor function as measured by serotonin-stimulated phosphoinositide hydrolysis in platelets of depressed patients. Progress in Neuropsychopharmacology and Biological Psychiatry. 1991;15:49–61
  28. Mori H, Koyama T, Yamashita I. Platelet alpha-2 adrenergic receptor-mediated phosphoinositide responses in endogenous depression. Life Sciences. 1991;48:741–748
  29. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature. 1988;334:661–665
  30. Osborne NN. Tricyclic antidepressants, mianserin, and ouabain stimulated inositol phosphate formation in vitro in rat cortical slices. Neurochemical Research. 1988;13:105–111
  31. Pacheco MA, Stockmeier C, Meltzer HY, Overholser JC, Dilley GE, Jope RS. Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Research. 1996;723:37–45
  32. Pandey GN, Dysken MW, Garver DL, Davis JM. β-Adrenergic receptor function in affective illness. American Journal of Psychiatry. 1979;136:675–678
  33. Pandey GN, Janicak PG, Davis J. Decreased beta-adrenergic receptors in the leukocytes of depressed patients. Psychiatry Research. 1987;22:265–273
  34. Pandey GN, Janicak PG, Javaid JI, Davis JM. Increased [3H]clonidine binding in the platelets of patients with depressive and schizophrenic disorders. Psychiatry Research. 1989;28:73–88
  35. Pandey GN, Pandey SC, Davis JM. Peripheral adrenergic receptors in affective illness and schizophrenia. Pharmacology and Toxicology. 1989;36:13–36
  36. Pandey SC, Davis JM, Schwertz DW, Pandey GN. Effect of antidepressants and neuroleptics on phosphoinositide metabolism in human platelets. Journal of Pharmacology and Experimental Therapeutics. 1991;256:1010–1018
  37. Pandey GN, Pandey SC, Dwivedi Y, Sharma RS, Janicak PG, Davis JM. Platelet serotonin2A receptors: a potential biological marker for suicidal behavior. American Journal of Psychiatry. 1995;152:850–855
  38. Pletscher A. Blood platelets as neuronal models: use and limitations. Clinical Neuropharmacology. 1986;9:344–346
  39. Potter WZ, Manji HK. Catecholamines in depression: an update. Clinical Chemistry. 1994;40:279–287
  40. Rhee SG, Bae YS. Regulation of phosphoinositide-specific phospholipase C isoenzymes. Journal of Biological Chemistry. 1997;272:15045–15048
  41. Ruggiero M, Lapetina EG. Leupeptin selectively inhibits human platelet responses induced by thrombin and trypsin: a role for proteolytic activation of phospholipase C. Biochemical and Biophysical Research Communications. 1985;131:1198–1205
  42. Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. American Journal of Psychiatry. 1965;122:509–522
  43. Soares JC, Dippold CS, Wells KF, Fran KE, Kupfer DJ, Mallinger AG. Increased platelet membrane phosphatidyl-inositol-4,5-bisphosphate in drug-free depressed bipolar patients. Neuroscience Letters. 2001;299:150–152
  44. Stahl SM. Peripheral models for the study of neurotransmitter receptors in man. Psychopharmacology Bulletin. 1985;21:663–761
  45. Taylor SJ, Chae HZ, Rhee SG, Exton JH. Activation of the beta 1 isozyme of phospholipase C by alpha subunits of the Gq class of G proteins. Nature. 1991;350:516–518
  46. Wachtel H. Dysbalance of neuronal second messenger function in the etiology of affective disorders: a pathophysiological concept hypothesizing defects beyond first messenger receptors. Journal of Neural Transmission. 1989;75:21–29

PII: S0165-1781(01)00337-7

Psychiatry Research
Volume 105, Issue 1 , Pages 23-32 , 15 December 2001

Article Tools

* Image Usage & Resolution